A bioactive peptide mixture was first injected on a high load SEC column (superdex 75)and fractionated. However due to the poor performance of the column, another superdex 75 from the same company was used as a second step to purify the fractions from the first SEC column, in this analysis the bioactivity of the fractions is gone.

what can be the reason for this?

Similar questions and discussions